Stocks · US
WST
XNYS
West Pharmaceutical Services, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E46.94x
P/B8.87x
P/S7.97x
EPS$8.03
ROE18.89%
ROA13.86%
Dividend yield0.22%
EV/EBITDA29.07x
Debt/Equity0.07
Free cash flow$437M
Returns and 52-week range
1W-1.06%
1M+9.61%
3M+5.36%
6M+43.68%
1Y+36.72%
YTD+34.82%
52W high$386.00
52W low$223.83
From 52W high-3.46%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| 앨나일램 파머슈티컬스 | $29.4B | 36.42 | 21.73 | -15.85% |
| Roivant Sciences Ltd. Common Shares | $25.8B | — | 6.11 | +1.72% |
| ZOETIS INC. | $29.5B | 11.28 | 9.37 | -5.91% |
| 퀘스트 다이어그노스틱스 | $25.6B | 24.20 | 3.41 | -3.69% |
| Mettler-Toledo International | $30.9B | 34.11 | 2,408.87 | +13.96% |
| Royalty Pharma plc Class A Ordinary Shares | $25.2B | 30.96 | 3.69 | -11.76% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.